Strengths

ACA’s liquidity is solid, with a 3.1 current ratio and 2.3 quick ratio, which compares favorably with many regional-bank peers facing tighter funding flexibility.

The company’s net debt to EBITDA of 1.7 suggests manageable leverage, supporting balance-sheet resilience versus more highly levered peers in the same lending cycle.

TTM ROIC of 5.8% indicates positive capital deployment, but it remains only middling versus stronger peers that consistently earn materially above cost of capital.

A cash conversion cycle of 98.6 days is not a structural advantage, yet it is less relevant for a bank model than funding mix and asset quality relative to peers.

Weaknesses

ACA’s ROIC of 5.8% points to limited value creation, leaving it behind higher-return peers that compound earnings more efficiently over a full credit cycle.

Net debt to EBITDA of 1.7 is acceptable, but it still leaves less flexibility than peers with stronger capital buffers and lower refinancing dependence.

The 98.6-day cash conversion cycle signals slower working-capital turnover than asset-light peers, which can constrain operating efficiency in a rising-rate environment.

Absent margin and growth metrics, ACA’s structural weakness versus peers is that its current profile does not show a clear earnings-quality or scale advantage.

Opportunities

If ACA improves capital efficiency from the current 5.8% ROIC, it could narrow the gap with better-performing peers and lift long-run relative returns.

The strong current and quick ratios provide room to support growth or absorb volatility better than peers with thinner liquidity, improving strategic flexibility.

Moderate leverage leaves capacity to optimize the balance sheet versus more indebted peers, which could enhance resilience if credit conditions tighten.

Because peer growth and segment data are unavailable, the main opportunity is execution-driven rather than structural, centered on converting balance-sheet strength into higher returns.

Threats

Peers with higher ROIC and stronger scale can compound faster, which threatens ACA’s relative positioning if its return profile remains near mid-single digits.

A 98.6-day cash conversion cycle can expose ACA to working-capital drag versus more efficient peers, especially if funding costs stay elevated.

Net debt to EBITDA of 1.7 leaves some sensitivity to earnings volatility, so weaker credit conditions could pressure relative flexibility versus less levered competitors.

Without evidence of superior growth or segment concentration advantages, ACA faces the threat of being structurally average while stronger peers capture disproportionate market share.

Overall Score

ACA’s positioning versus peers is broadly average, with solid liquidity offset by only middling capital efficiency and no clear structural advantage in the available data.